Annovis BioAdvance News Portfolio News

Annovis Bio Appoints Henry Hagopian III as Chief Financial Officer

By WebmasterAugust 29, 2022November 1st, 2024No Comments

Annovis Bio Appoints Henry Hagopian III as Chief Financial Officer

Previous PostInnervace Secures Up to $40 Million to Advance Novel Regenerative Medicine Platform for Neurological Disorders
Next PostAnnovis Bio Announces First Patient Dosed in Phase 3 Trial in Patients with Early Parkinson's Disease